Inactive Instrument

News Orletto Capital Inc Toronto S.E.

Equities

OLEp

CA6866681043

End-of-day quote Toronto S.E. Other stock markets
-	-

06-25	Devonian Health Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	CI
06-03	Devonian Health Group Founder Assumes Chair, COO Roles	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK'S CHICAGO VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JULY 17, 2024	07-16	AQ
DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK'S LOS ANGELES VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JULY 10, 2024	07-09	AQ
DEVONIAN HEALTH : TO PARTICIPATE IN RENMARK’S BOSTON VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JUNE 26, 2024	06-25	PU
Devonian Health Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	06-25	CI
Devonian Health : Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor relations Firm	06-25	PU
Devonian Health Group Founder Assumes Chair, COO Roles	06-03	MT
Devonian Health Group Inc. Appoints André P. Boulet to Chairman of the Board and Chief Operating Officer	06-03	CI
Devonian Health Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	03-28	CI
Devonian Announces Closing of a Private Placement of Units	03-15	AQ
Devonian Health Group Closes Non-Brokered Private Placement; Down Nearly 7%	03-14	MT
Devonian Health Group Inc. announced that it has received CAD 0.2238 million in funding	03-12	CI
DEVONIAN HEALTH NAMES KATHRYN J. GREGORY TO THE BOARD OF DIRECTORS AND GRANTS STOCK OPTIONS	03-01	AQ
Devonian Health Group Inc. Appoints Kathryn J. Gregory to the Board	02-29	CI
Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole in Canada	02-28	AQ
Devonian Announces $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan	02-26	CI
DEVONIAN BOLSTERS INTELLECTUAL PROPERTY WITH ISSUANCE OF U.S. PATENT COVERING A METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE	02-21	AQ
Devonian Health Group Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	12-22	CI
DEVONIAN BOLSTERS LEADERSHIP TEAM AND ALIGNS STRATEGY TO ACCELERATE CLINICAL DEVELOPMENT AND DRIVE REVENUE GROWTH AND COMMERCIAL SUCCESS	12-05	AQ
Devonian Health Group Inc. Announces CEO Changes	12-04	CI
Devonian Health Group Inc. Announces Changes to its Board	12-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Orletto Capital Inc Toronto S.E.

Equities

OLEp

CA6866681043

Summary

Filters